S&P 500 Industrials Sector SEC Filings — February 24, 2026

25-02-2026

Ionis Pharmaceuticals Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are explicitly stated in the provided filing details. This is a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

25-02-2026

BAB, INC. filed an 8-K on February 25, 2026 (AccNo: 0001437749-26-005604), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No specific details on the nature of the accountant change, reasons, prior or new auditor names, disagreements, financial impacts, or quantitative metrics are disclosed. This is a mandatory disclosure with potential implications for financial reporting integrity.

25-02-2026

FIRST MID BANCSHARES, INC. filed a Form 8-K on February 25, 2026 (AccNo: 0001171843-26-001082, Size: 187 KB), reporting solely under Item 8.01 Other Events. No details on the core event, financial impacts, transaction values, or metrics are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or directional implications available.

25-02-2026

National Storage Affiliates Trust filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or period-over-period changes were disclosed in the provided filing details. This represents a standard voluntary disclosure of financial results with attached exhibits.

25-02-2026

Metropolitan Bank Holding Corp. filed a Form 8-K on February 25, 2026 (AccNo: 0001104659-26-019661, Size: 229 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transactions, guidance, or other quantitative details are explicitly stated in the provided filing information. The disclosure appears informational without specified positive or negative impacts.

25-02-2026

LIGHTBRIDGE Corp filed an 8-K on February 25, 2026, pursuant to Item 2.02 announcing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure with all quantitative financial impacts NOT_DISCLOSED.

25-02-2026

Pitney Bowes Inc. /DE/ filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-068707, size: 174 KB) reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. No positive or negative performance indicators, scheduled events, or strategic details are mentioned.

25-02-2026

25-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events, which discloses a material event not covered by other specific items. The filing also includes Item 9.01 Financial Statements and Exhibits, indicating attachments such as financial data or agreements. No specific details on the event, transaction values, financial metrics, or performance comparisons are disclosed in the provided filing summary.

25-02-2026

Battalion Oil Corp filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 includes financial statements and exhibits, likely pro forma financials related to the transaction. No specific details on deal structure, parties, valuation, synergies, or quantitative metrics are disclosed in the provided filing information.

25-02-2026

Luminar Technologies, Inc./DE filed an 8-K on February 25, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are explicitly stated in the provided filing information. The disclosure appears informational with attached exhibits, but core content is NOT_DISCLOSED.

25-02-2026

Recursion Pharmaceuticals, Inc. filed an 8-K on February 25, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other metrics. No period-over-period comparisons, guidance, or directional performance indicators (positive, negative, or flat) are mentioned.

25-02-2026

Aspen Aerogels Inc filed an 8-K on 2026-02-25 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.

25-02-2026

Alexander & Baldwin, Inc. filed a Form 8-K on February 25, 2026, specifically under Item 8.01 Other Events. No details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This appears to be a single-item filing with no quantitative data or period-over-period comparisons mentioned.

25-02-2026

Photronics Inc filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006717), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Size: 6 MB
• ·Sector: not specified

25-02-2026

O-I Glass, Inc. filed an 8-K on February 25, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

25-02-2026

Steven Madden, Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-007955, Size: 536 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing description. This appears to be a standard multi-item earnings-related disclosure with sector NOT_DISCLOSED.

25-02-2026

Lineage, Inc. filed an 8-K on February 25, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results on a voluntary basis. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data are provided in the filing details.

25-02-2026

Ironwood Pharmaceuticals Inc filed an 8-K on February 25, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard financial results announcement with no period-over-period comparisons or directional indicators available.

25-02-2026

Geron Corp filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics were mentioned in the filing summary. This is a standard multi-item earnings-related disclosure with no directional financial performance data provided.

25-02-2026

Dine Brands Global, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-068524), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, margins, comparisons, guidance, or other numerical metrics are disclosed in the provided information.

25-02-2026

Angel Oak Mortgage REIT, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are detailed in the provided information. No positive or negative performance indicators, guidance, or comparisons were mentioned.

25-02-2026

Immunocore Holdings plc filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified metrics available.

• ·Sector not specified in filing.
• ·No details on market expectations, guidance changes, or balance sheet effects provided.

25-02-2026

Corbus Pharmaceuticals Holdings, Inc. filed a Form 8-K on February 25, 2026, under Item 7.01 Regulation FD Disclosure, which is a voluntary release of material non-public information to ensure broad dissemination, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents such as a press release or presentation (file size 22 MB). No specific transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing summary. This is a multi-item, primarily voluntary disclosure with no details on timing relative to the 4-business-day requirement.

25-02-2026

NEWMARK GROUP, INC. filed an 8-K on 2026-02-25 reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided filing information. No positive or negative financial changes can be assessed due to lack of extracted data.

25-02-2026

UWM Holdings Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, or other metrics are disclosed in the provided filing information.

25-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement terms, equity sales volume, or disclosures are provided. This is a multi-item mandatory filing with no quantitative impacts or period-over-period comparisons disclosed.

25-02-2026

Totaligent, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, financial impacts, or other metrics are provided in the filing summary.

25-02-2026

DevvStream Corp. filed an 8-K on February 25, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or strategic implications are mentioned.

25-02-2026

IPG Photonics Corp filed a Form 8-K on February 25, 2026, under Item 8.01 Other Events. The filing has Accession Number 0001111928-26-000051 and a size of 225 KB. No specific details on the event, financial metrics, transactions, or quantitative data are disclosed.

25-02-2026

INTELLIGENT BIO SOLUTIONS INC. filed an 8-K on 2026-02-25 under Item 7.01 (Regulation FD Disclosure) to publicly disclose material nonpublic information and Item 9.01 (Financial Statements and Exhibits), indicating attached documents such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata. This is a multi-item, likely mandatory compliance filing for Reg FD with no directional financial impact evident.

25-02-2026

TJX COMPANIES INC /DE/ filed an 8-K on 2026-02-25 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

Salarius Pharmaceuticals, Inc. filed an 8-K on February 25, 2026, specifically under Item 5.07 reporting Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting. No specific proposals, vote outcomes, numerical tallies, or financial impacts are disclosed in the provided filing information. This is a standard post-meeting informational disclosure with no mentioned positive or negative developments.

25-02-2026

RANGE RESOURCES CORP filed an 8-K on February 25, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or quantitative details are provided in the filing summary. This appears to be a standard earnings-related disclosure, but all key performance indicators are NOT_DISCLOSED.

25-02-2026

Eton Pharmaceuticals, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. This appears to be an informational disclosure without quantified financial or operational metrics.

25-02-2026

TriLinc Global Impact Fund LLC filed a Form 8-K on February 25, 2026, disclosing under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or quantitative data are mentioned. This is an informational filing with no disclosed positive or negative impacts.

25-02-2026

AmBase Corp filed an 8-K on 2026-02-25 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on the agreement's parties, terms, value, or financial impacts provided. No quantitative metrics, comparisons, or scheduled events are disclosed.

25-02-2026

Barrett Business Services Inc filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071531), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet effects, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

25-02-2026

MIDDLEFIELD BANC CORP filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, timing, or financial details are mentioned. No quantitative metrics, performance comparisons, or other impacts are provided.

25-02-2026

PUBLIC CO MANAGEMENT CORP filed an 8-K on 2026-02-25 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the nature of the agreement, events, or any financial metrics. All quantitative data, transaction values, impacts, or scheduled events are NOT_DISCLOSED.

25-02-2026

Schrodinger, Inc. filed an 8-K on 2026-02-25 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), with AccNo 0001490978-26-000009 and file size 406 KB. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or other metrics are mentioned. No positive or negative performance details, period-over-period comparisons, or strategic updates are provided.

25-02-2026

Red Robin Gourmet Burgers Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing details. This is a standard earnings-related disclosure with attached exhibits likely containing the detailed financial metrics.

• ·AccNo: 0001628280-26-011637
• ·Event Type: Financial Results
• ·Source: us_sec

25-02-2026

Trade Desk, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001671933-26-000009), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This multi-item filing signals an earnings release but lacks quantitative details for impact assessment.

25-02-2026

SmartStop Self Storage REIT, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071534), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure without detailed performance data available.

25-02-2026

Zoom Communications, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information. This appears to be a voluntary disclosure of financial results with attached exhibits.

25-02-2026

KEWAUNEE SCIENTIFIC CORP /DE/ filed an 8-K on February 25, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the content of financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics or directional impacts provided.

25-02-2026

Pure Storage, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with no detailed performance data available.

25-02-2026

Climb Global Solutions, Inc. filed an 8-K on 2026-02-25 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific financial metrics, revenue, earnings, guidance, or quantitative data are mentioned in the filing description. This is a multi-item filing typical for earnings announcements.

25-02-2026

NIOCorp Developments Ltd filed a Form 8-K on 2026-02-25 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary. This is a multi-item filing with no disclosed transaction values, performance metrics, or directional implications.

• ·Multi-item 8-K filing (Items 1.01, 7.01, 8.01, 9.01)
• ·AccNo: 0001539497-26-000783, Size: 821 KB
• ·Sector: not specified

25-02-2026

Honest Company, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on the officer change, such as name, title, reason, or timing, are provided. No financial metrics, quantitative data, or performance comparisons are disclosed.

25-02-2026

Dermata Therapeutics, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or further implications are disclosed.

25-02-2026

Mirum Pharmaceuticals, Inc. filed an 8-K on 2026-02-25 disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, transaction values, or period-over-period comparisons were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

25-02-2026

CSB Bancorp, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071483, size 184 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.

25-02-2026

Park Dental Partners, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. This is a standard earnings-related filing, but specific revenue, earnings, margins, period-over-period changes, or guidance are NOT_DISCLOSED. No positive or negative metrics, flat performance, or comparisons are provided in the excerpt.

25-02-2026

Celldex Therapeutics, Inc. filed an 8-K on February 25, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.

25-02-2026

Cherry Hill Mortgage Investment Corp filed an 8-K on 2026-02-25 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information.

25-02-2026

KRONOS WORLDWIDE INC filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), name, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

25-02-2026

Generation Income Properties, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071590, Size: 383 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This appears to be a single-item mandatory disclosure with no quantitative metrics, positive or negative changes, or period-over-period comparisons mentioned.

25-02-2026

Ibotta, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011669), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, or period-over-period metrics are explicitly stated in the provided filing details.

25-02-2026

FirstSun Capital Bancorp filed a Form 8-K on February 25, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, financial metrics, transactions, or exhibits are provided in the filing summary. The disclosure appears informational with no quantified positive or negative impacts mentioned.

25-02-2026

DigitalBridge Group, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed results excerpted.

25-02-2026

Pursuit Attractions & Hospitality, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071572), reporting Results of Operations and Financial Condition under Item 2.02 and attaching Financial Statements and Exhibits under Item 9.01. This is a standard disclosure for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics detailed in the provided filing information. No positive or negative financial changes were disclosed.

25-02-2026

Barnwell Industries Inc filed an 8-K on February 25, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's terms, parties, value, strategic rationale, or financial impacts are provided in the filing summary. This appears to be a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons mentioned.

25-02-2026

Eagle Bancorp Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual, reason for change, or timing are disclosed.

25-02-2026

International Battery Metals Ltd. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071717), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data.

25-02-2026

Catalyst Pharmaceuticals, Inc. filed a Form 8-K on February 25, 2026 (AccNo: 0001193125-26-071702), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the Other Events, transaction values, financial metrics, or exhibits are disclosed. No positive or negative metrics are mentioned.

25-02-2026

Marriott Vacations Worldwide Corp filed an 8-K on February 25, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details, period-over-period comparisons, or transaction values are mentioned.

25-02-2026

Global Net Lease, Inc. filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. All quantitative data and performance indicators are NOT_DISCLOSED.

25-02-2026

ACADIA PHARMACEUTICALS INC filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure with no mentioned positive or negative performance indicators.

25-02-2026

Seritage Growth Properties filed a Form 8-K on February 25, 2026, under Item 8.01 Other Events. No details on the specific event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or scheduled events mentioned.

25-02-2026

Ingevity Corp filed an 8-K on 2026-02-25 under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

25-02-2026

OGE Energy Corp. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071800), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial impacts, or governance implications are provided.

25-02-2026

Bimergen Energy Corp filed an 8-K on February 25, 2026 (AccNo: 0001493152-26-008049), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.

25-02-2026

LandBridge Co LLC filed an 8-K on February 25, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative performance data were disclosed in the provided filing information. No positive, negative, or flat metrics were mentioned.

25-02-2026

Global Medical REIT Inc. filed a multi-item 8-K on February 25, 2026, reporting results of operations and financial condition (Item 2.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific financial metrics, dollar values, period-over-period changes, or quantitative impacts are disclosed in the provided filing details. This filing provides informational disclosures without detailed performance data.

25-02-2026

Stellar Bancorp, Inc. filed a Form 8-K on February 25, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events or exhibits provided in the summary. No quantitative financial metrics, transactions, or directional impacts are disclosed.

25-02-2026

Sealed Air Corp/DE filed an 8-K on February 25, 2026, reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely disclosing shareholder meeting voting results and unspecified other events, with attached exhibits. No financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

25-02-2026

Bath & Body Works, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, reasons, or timing are disclosed.

25-02-2026

PEDEVCO CORP filed an 8-K on 2026-02-25 reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases, with no quantitative data available.

25-02-2026

Tevogen Bio Holdings Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, names, reasons for changes, vote outcomes, or exhibits are disclosed.

25-02-2026

urban-gro, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details on transaction terms, values, or impacts disclosed. No quantitative financial metrics, positive or negative changes, or period-over-period comparisons are mentioned.

25-02-2026

25-02-2026

DIRTT Environmental Solutions Ltd filed an 8-K on February 25, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue figures, earnings, comparisons, or other quantitative data are disclosed in the provided filing information. This is a standard disclosure for financial results with no details on performance direction.

25-02-2026

Manhattan Bridge Capital, Inc. filed an 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·Filing Accession Number: 0001493152-26-008061
• ·Filing size: 321 KB
• ·Sector: NOT_DISCLOSED

25-02-2026

Catalyst Crew Technologies Corp. filed an 8-K on 2026-02-25 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The transaction triggered changes in control of the registrant (Item 5.01), departure or election of directors and officers with compensatory arrangements (Item 5.02), a change in shell company status (Item 5.06), and unregistered sales of equity securities (Item 3.02). No financial terms, parties involved, valuations, or quantitative metrics were disclosed.

25-02-2026

Ideal Power Inc. filed a Form 8-K on February 25, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory and voluntary disclosure with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the filing summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.